跳到主要內容

SkyKnight Capital Fund II, L.P. 的 Form 4 申報

AdaptHealth Corp.(AHCO),2023/8/14 申報

申報編號
0000950170-23-042448
申報時間
2023/8/14 16:23 ET
交易日
2023/8/10-8/11
申報延遲
4 天
10b5-1 計畫
沒有勾選

這份申報列了 4 筆非衍生性交易。公開市場賣出合計 $456.8 萬。交易後 4 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
SkyKnight Capital Fund II, L.P.CIK 0001748212董事
SkyKnight Aero Holdings, LLCCIK 0001793034董事
Ebbel MatthewCIK 0001842704董事
SkyKnight Capital II GP, LLCCIK 0001842706董事
SkyKnight Capital, L.P.CIK 0001842707董事
SkyKnight Capital Management, LLCCIK 0001842708董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2023/8/10Common StockS賣出處分−90,152$14.05F1−$1,266,293.022,952,904直接
2023/8/10Common StockS賣出處分−38,636$14.05F1−$542,688.985,624,178間接
2023/8/11Common StockS賣出處分−137,787$14.02F4−$1,931,084.812,815,117直接
2023/8/11Common StockS賣出處分−59,052$14.02F4−$827,613.785,565,126間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

表 I 有 2 筆交易的價格引用這則附註。

F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.06. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

表 I 有 2 筆交易的價格引用這則附註。

備註

Theodore B. Lundberg has been deputized to represent the Reporting Persons on the board of directors of the Issuer. By virtue of Mr. Lundberg's representation, for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Exchange Act"), each of the Reporting Persons may be deemed directors by deputization of the Issuer. This filing shall not be deemed an admission that any Reporting Person is a beneficial owner of the securities reported in this filing for purposes of Section 16 of the Exchange Act or otherwise, or is subject to Section 16 of the Exchange Act, and each Reporting Person disclaims beneficial ownership of these securities, except to the extent of such Reporting Person's pecuniary interest therein, if any.

看 SEC EDGAR 上的完整原文 (在新分頁開啟)